Skip to content

144/AAccepted May 26, 9:57 AM ET

EyePoint Pharmaceuticals, Inc. 144/A

Ocumension Therapeutics

sec.gov(opens the filing on sec.gov)

Accepted (ET)

9:57 AM

May 26, 2023

Filed

May 26, 2023

Documents

1

Size

5.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.